Effect of Eldcalcitol/ Raloxifene combination therapy for fall prevention in primary osteoporosis patients: a randomized controlled study.
Not Applicable
Recruiting
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000008216
- Lead Sponsor
- igata Rehabilitation Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who are diagnosed as contraindication of raloxifene treatments 2.Patients who are diagnosed as contraindication of eldecalcitol treatments 3.Treated medicine that may affect bone metabolism 4.Patients with cancer 5.Patients who are inappropriate for this study by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of patients with fall
- Secondary Outcome Measures
Name Time Method Change of lumbar spine bone mineral density Change of total hip bone mineral density Change of bone metabolic markers Fall risk assessment tools Safty